Information  X 
Enter a valid email address

XL TechGroup, Inc. (XLT)


Friday 01 June, 2007

XL TechGroup, Inc.

TyraTech 1st day of Dealings

XL TechGroup, Inc.
01 June 2007

Press Release                                                      1 June 2007

                               XL TechGroup, Inc.
                       ('XL TechGroup' or 'the Company')

                         TyraTech First Day of Dealings

XL TechGroup (AIM: XLT), the systematic architect and builder of an ongoing
stream of high value new companies, is pleased to announce that trading in the
ordinary shares of its second company, TyraTech Inc. ('TyraTech') (AIM: TYR),
the pioneer of safer, effective and natural pesticide products, has begun on

Admission to trading follows a Placing of TyraTech's Ordinary Shares, which
raised £25 million before expenses at the Placing Price of 500 pence per share.
TyraTech has a market capitalisation of £110 million based on the Placing price.

XL TechGroup holds a 47.92% interest in TyraTech.

Dr. John Scott, CEO of XL TechGroup, said: 'Our confidence in TyraTech is
underpinned by the fact that we have not sold any shares as part of the IPO
placing and are supportive and enthusiastic shareholders.  This successful IPO
further validates our continuing process of significant value creation.'

                                    - Ends -

For further information:
XL TechGroup Inc.
John Scott / Harold Gubnitsky                               Tel: +1 321 409 7403
[email protected]                                       
Chris Munden, Director of Investor Relations           Tel: +44 (0) 20 7398 7720
[email protected]                                   

Nomura Code Securities
Richard Potts, Corporate Finance                       Tel: +44 (0) 20 7776 1200

XL TechGroup media enquiries:
Abchurch Communications
Heather Salmond / Gareth Mead                          Tel: +44 (0) 20 7398 7700
[email protected]              


About XL TechGroup

XL TechGroup is in the business of significant value creation.  Working with
major international corporate and technology partners such as AES, Procter &
Gamble and leading universities, XL TechGroup first identifies global unmet
market needs and then targets and exploits these by the systematic creation of
successful, disruptive technology businesses.  These are built from scratch, and
are then funded and developed by XL TechGroup through to the point of a trade
sale or a stock market listing.

XL TechGroup's unique and proven methodology selects the best opportunities in
order to create one-to-two new companies annually, where each company is
expected to achieve a realisable valuation of at least US$400 million within
four years from its creation.  While an XL TechGroup company might perform a
stock market listing at an earlier point in this four year timeframe, XL
TechGroup would retain its controlling interest and would continue to assist
with the company's development.

XL TechGroup's companies to date are: AgCert International plc (,
TyraTech Inc. (, DxTech LLC (, PetroAlgae LLC
( and QuoNova LLC (

XL TechGroup has also established GenXL LLC ( as a joint venture to
capture the value of those prospects that do not quite meet the US$400 million,
four year criteria but still demonstrate considerable potential worth.  Over and
above XL TechGroup's core business model, GenXL will review a significant flow
of opportunities from both XL TechGroup and GEN3 in order to generate new
companies, standalone product lines and technology licensing opportunities or an
appropriate mix of these.

For further information, see

About TyraTech

TyraTech is pioneering a new class of highly effective pesticides and
anti-parasitic compounds to address global markets in agriculture, horticulture,
functional foods, healthcare and veterinary science.  Using a proprietary
chemoreceptor screening process, TyraTech has identified both individual, and
combinations of, natural oil compounds that bind to neurological and olfactory
receptors of insects and parasites so that they can be effectively repelled or
killed.  TyraTech's natural product lines are designed to selectively target
invertebrates, but not humans or other mammals, and overcome resistance through
attacking multiple sensitive biologic receptors.

TyraTech has developed multiple routes to market for its products including
through strong partnerships with major multi-national commercialisation partners
such as Syngenta Crop Protection AG; The Scotts Company LLC; Arysta LifeScience
North America Corporation; and Kraft Foods Holdings, Inc.

For further information, see

                      This information is provided by RNS
            The company news service from the London Stock Exchange                                                                                                                                   

a d v e r t i s e m e n t